Cargando…

Use of Second-line Immunotherapy in Control Arms of Randomized Clinical Trials in Kidney Cancer: A Systematic Review

IMPORTANCE: Immunotherapy (anti–programmed death ligand 1 antibodies) is associated with improved survival rates in advanced kidney cell carcinoma (KCC) after progression on first-line tyrosine kinase inhibitor (TKI) treatment. It is unknown whether and to what degree patients in the control arm rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharp, John, Khaki, Ali Raza, Prasad, Vinay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477261/ https://www.ncbi.nlm.nih.gov/pubmed/34570209 http://dx.doi.org/10.1001/jamanetworkopen.2021.24728

Ejemplares similares

Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials: A Systematic Review
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2021)

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
por: Haslam, Alyson, et al.
Publicado: (2019)

Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019
por: Lythgoe, Mark P., et al.
Publicado: (2022)

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial
por: Taïeb, Julien, et al.
Publicado: (2023)

Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of Nivolumab
por: Chiang, Ryan S, et al.
Publicado: (2022)

Clinical Trials Portfolio and Regulatory History of Idelalisib in Indolent Non-Hodgkin Lymphoma: A Systematic Review and Meta-analysis
por: Banerjee, Titas, et al.
Publicado: (2023)

Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis
por: Haas, Julia W., et al.
Publicado: (2022)

Effectiveness of a question formulation rubric with second-year medical students: a randomized controlled trial
por: Eldredge, Jonathan D., et al.
Publicado: (2023)

An estimate of rate of deviation from NCCN guideline recommendations for central nervous system imaging in trials forming basis for drug approval in first line advanced non-small cell lung cancer (NSCLC)
por: Sharp, John, et al.
Publicado: (2022)

Second-Line Pharmaceutical Treatments for Patients with Type 2 Diabetes
por: Vashisht, Rohit, et al.
Publicado: (2023)

Characteristics of Registered Studies of Chimeric Antigen Receptor Therapies: A Systematic Review
por: Banerjee, Rahul, et al.
Publicado: (2021)

Incidence of Placebo Adverse Events in Randomized Clinical Trials of Targeted and Immunotherapy Cancer Drugs in the Adjuvant Setting: A Systematic Review and Meta-analysis
por: Chacón, Matías Rodrigo, et al.
Publicado: (2018)

Cost-effectiveness of Pembrolizumab as a Second-Line Therapy for Hepatocellular Carcinoma
por: Chiang, Chi-leung, et al.
Publicado: (2021)

Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022
por: Mousavi, Idine, et al.
Publicado: (2022)

Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial
por: Huffman, Brandon M., et al.
Publicado: (2023)

Association of Adjuvant or Metastatic Setting With Discontinuation of Cancer Drugs in Clinical Trials
por: Ahmed, Nibras, et al.
Publicado: (2022)

Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis
por: Yang, Fang, et al.
Publicado: (2020)

Frequency and Characteristics of Trials Using Medical Writer Support in High-Impact Oncology Journals
por: Buck, Eva, et al.
Publicado: (2023)

Patient Experience Captured by Quality-of-Life Measurement in Oncology Clinical Trials
por: Haslam, Alyson, et al.
Publicado: (2020)

Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review
por: Hansford, Harrison J., et al.
Publicado: (2023)

A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
por: Werlenius, Katja, et al.
Publicado: (2021)

Efficiency of Electronic Health Record Assessment of Patient-Reported Outcomes After Cancer Immunotherapy: A Randomized Clinical Trial
por: Zhang, Liyan, et al.
Publicado: (2022)

Imaging-associated stress causes divergent phase transitions of RNA-binding proteins in the Caenorhabditis elegans germ line
por: Elaswad, Mohamed T, et al.
Publicado: (2022)

Reassignment of Drosophila willistoni Genome Scaffolds to Chromosome II Arms
por: Garcia, Carolina, et al.
Publicado: (2015)

Changes Induced by Early Hand-Arm Bimanual Intensive Therapy Including Lower Extremities in Young Children With Unilateral Cerebral Palsy: A Randomized Clinical Trial
por: Araneda, Rodrigo, et al.
Publicado: (2023)

HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial
por: Claassen, Cassidy W., et al.
Publicado: (2019)

The Origin of the Second Centriole in the Zygote of Drosophila melanogaster
por: Blachon, Stephanie, et al.
Publicado: (2014)

Effects of Plasma-Lyte.½ and 0.9% saline in renal function after deceased-donor kidney transplant: a randomized controlled trial
por: do Nascimento Junior, Paulo, et al.
Publicado: (2021)

Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials
por: Luo, Chengxin, et al.
Publicado: (2023)

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial
por: Singh, Ajay K., et al.
Publicado: (2022)

Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial
por: Gerber, Ben S., et al.
Publicado: (2023)

Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure: A Nonrandomized Clinical Trial
por: Zhang, Xiangyu, et al.
Publicado: (2020)

Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2021)

An alternative approach for blocking the superior trunk of the brachial plexus evaluated by a single arm clinical trial
por: Frederico, Thiago Nouer, et al.
Publicado: (2021)

Effect of a Novel Multicomponent Intervention to Improve Patient Access to Kidney Transplant and Living Kidney Donation: The EnAKT LKD Cluster Randomized Clinical Trial
por: Garg, Amit X., et al.
Publicado: (2023)

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial
por: Qin, Shukui, et al.
Publicado: (2023)

Comparison of totally tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a randomized, clinical trial
por: Moosanejad, N., et al.
Publicado: (2016)

Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?
por: Moliner, L., et al.
Publicado: (2023)

Trends of Randomized Clinical Trials Citing Prior Systematic Reviews, 2007-2021
por: Jia, Yuanxi, et al.
Publicado: (2023)

Variable Transposition of Eight Maize Activator (Ac) Elements Located on the Short Arm of Chromosome 1
por: Sheridan, William F.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bhaf5l622ijkvssuv1acenmb5s